Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Rani Therapeutics Holdings (RANI) Leases (2022 - 2026)

Rani Therapeutics Holdings' Leases history spans 5 years, with the latest figure at $3.9 million for Q1 2026.

  • On a quarterly basis, Leases fell 17.0% to $3.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.9 million, a 17.0% decrease, with the full-year FY2025 number at $4.3 million, down 15.27% from a year prior.
  • Leases came in at $3.9 million for Q1 2026, down from $4.3 million in the prior quarter.
  • The five-year high for Leases was $6.0 million in Q1 2024, with the low at $718000.0 in Q4 2023.
  • Historically, Leases has averaged $3.1 million across 5 years, with a median of $3.9 million in 2026.
  • Biggest five-year swings in Leases: plummeted 32.58% in 2023 and later skyrocketed 609.75% in 2024.
  • Year by year, Leases stood at $1.1 million in 2022, then crashed by 32.58% to $718000.0 in 2023, then soared by 609.75% to $5.1 million in 2024, then dropped by 15.27% to $4.3 million in 2025, then dropped by 8.73% to $3.9 million in 2026.
  • Business Quant data shows Leases for RANI at $3.9 million in Q1 2026, $4.3 million in Q4 2025, and $4.0 million in Q3 2025.